Skip to main content
OpenTrials
Completed

NCT Number: NCT06568991

The Effect of Low-protein Rice on Nutritional Status and Other Outcomes of Patients With Chronic Kidney Disease.(KS01)

1. To examine nutrient intake change in chronic kidney disease patients consuming " Low Protein Rice MATSUBUMAI "compared to a regular care group at 0,1,3,6 month. 2. To assess nutritional status improved or maintained after low protein rice intervention. 3. To assess whether the patient's renal function improved or maintained after low protein rice intervention.

Completed

Looking for future studies?

Notify Me

Key information

About this study

  • Recruited the subjects procedures A physical checking the history and blood biochemical data will be carried out by the study physician to verify eligibility for enrollment study at outpatient. A physical explain and answer about the study procedure and criteria to subjects.

Subjects review informed consent and sign it.

  • The trail procedures(brief describe)

1.After the subjects will sign informed consent form at the outpatient, they will be enrolled (phone) and schedule study visit1 (M0) by study staff. 2.The study visit1 will collect demographics, blood, urine and distribute product and product consumption diaries, and perform SGA (Subjective Global Assessment). 3.The study visit2 (M1), after the product be used for 4 weeks, will collect adverse event, blood,urine, and SGA. 4.The study visit3(M3), after the product be used for 12 weeks, will collect adverse event, blood,urine, and SGA. 5.The study visit4(M6), after the product be used for 24 weeks, will collect adverse event, blood,urine, and SGA. 3.Subject and study design: Investigators will recruit 100 subjects participating in the"PRE-ESRD education plan" at KMUH.

Subjects will receive dietary education of low protein diet (providing energy 25 to 35 Kcal/Kg/day, protein 0.6 to 0.8 g/Kg/day) by dietitians. Subjects will be randomly assigned to a observational group or rue low protein rice group. Observational group (n=40): Forty subjects will be enrolled. Subjects will receive routine dietary education of low protein diet. True Low Protein Rice group (n=60): Subjects will replace regular staple foods with low protein rice. Subjects will replace regular staple foods with low protein rice at levels of 40-160grams/ day. According to subjects' intake, subjects will be further divided into low & high intake groups for analysis. High intake group: Subjects consuming low Protein Rice at levels of 81-160 grams/day. Low intake group: Subjects consuming low Protein Rice at levels of 40-80 grams/day.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Exclusion criteria

s

  • were undergoing dialysis
  • had cancer under any treatmen
  • had any major surgery before or after the study period
  • were pregnant or breastfeeding
  • were diagnosed with alcoholism
  • had liver, gastrointestinal tract, or other metabolic diseases
  • and/or had been determined by a physician to be clinically unstable.
  • Subject is participating in another study that has not been approved as a concomitant study by Low Protein Rice.
  • Subjects consuming oral nutritional supplement(ONS) >3 times/week for the control group and subjects consuming any ONS for the low protein rice group.

Inclusion criteria

  • Patients were diagnosed with stages 3b-5 CKD with an estimated glomerular filtration rate (eGFR) of 15-44 mL/min/1.73 m2.
  • Patients were aged 30-70 years
  • Patients received pre-end-stage renal disease (pre-ESRD) care under a pay-for-performance program (P4P) at the Department of Nephrology at Kaohsiung Medical University Hospital.

Treatment and study plan

Low Protein Rice MATSUBUMAI

Dietary Supplement

Investigators will recruit 100 subjects participating in the"PRE-ESRD education plan" at KMUH. Subjects will receive dietary education of low protein diet (providing energy 25 to 35 Kcal/Kg/day, protein 0.6 to 0.8 g/Kg/day) by dietitians. Subjects will be randomly assigned to a observational group or rue low protein rice group.

Primary outcomes

  1. albumin (g/dL)

    Time frame: baseline, 6 month

    nutritional indicators

  2. nitrogen balance (g/day)

    Time frame: baseline, 6 month

    nutritional indicators

  3. handgrip strength (kg)

    Time frame: baseline, 6 month

    nutritional indicators

  4. blood urea nitrogen (mg/dL)

    Time frame: baseline, 6 month

    residual renal function

  5. creatinine (mg/dL)

    Time frame: baseline, 6 month

    residual renal function

  6. estimated glomerular filtration rate (eGFR) (mL/min/1.73m2)

    Time frame: baseline, 6 month

    residual renal function

Secondary outcomes

  1. Body weight (kg)

    Time frame: baseline, 6 month

    Body composition

  2. muscle mass (kg)

    Time frame: baseline, 6 month

    Body composition

  3. fat mass (%)

    Time frame: baseline, 6 month

    Body composition

  4. energy intake (Kcal/day)

    Time frame: baseline, 6 month

    Nutrient intakes

  5. protein intake (g/day)

    Time frame: baseline, 6 month

    Nutrient intakes

  6. potassium (mmol/L)

    Time frame: baseline, 6 month

    electrolytes

  7. phosphorus (mg/dL)

    Time frame: baseline, 6 month

    electrolytes

Sponsors and collaborators

Lead sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital

Other

Collaborators

  • TAIWAN KITOKU CO., LTD.

Registry information

Official study title

The Effect of Low-protein Rice on Nutritional Status and Other Outcomes of Patients With Chronic Kidney Disease.

Important dates

Study start
2015
Primary completion
2019
Study completion
2019
First posted
Aug 23, 2024
Registry last updated
Aug 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.